Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)

Basit Öğe Kaydı
dc.authoridTufekcioglu, Omac/0000-0003-3478-9292
dc.authoridKilickiran Avci, Burcak/0000-0001-9285-0608
dc.authoridKAYIKCIOGLU, MERAL/0000-0003-3692-5227
dc.authoridYILMAZ, Mehmet Birhan/0000-0002-8169-8628;
dc.authorwosidTufekcioglu, Omac/AAE-4660-2020
dc.authorwosidKAYIKCIOGLU, Meral/AAH-6687-2020
dc.authorwosidErmis, Necip/HJP-7061-2023
dc.authorwosidKilickiran Avci, Burcak/C-9766-2016
dc.authorwosidOngen, Zeki/HZL-8534-2023
dc.authorwosidKucukoglu, Serdar/AAC-8843-2021
dc.authorwosidAvci, Burcak Kilickiran/D-1314-2016
dc.contributor.authorKaymaz, Cihangir
dc.contributor.authorMutlu, Bulent
dc.contributor.authorKucukoglu, M. Serdar
dc.contributor.authorKaya, Baris
dc.contributor.authorAkdeniz, Bahri
dc.contributor.authorAvci, Burcak Kilickiran
dc.contributor.authorAksakal, Enbiya
dc.date.accessioned2024-08-04T20:09:52Z
dc.date.available2024-08-04T20:09:52Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: The present study was designed to evaluate the characteristics of pulmonary hypertension (PH) and adult cardiology practice patterns for PH in our country. Methods: We evaluated preliminary survey data of 1501 patients with PH (females, 69%; age, 44.8 +/- 5.45) from 20 adult cardiology centers (AdCCs). Results: The average experience of AdCCs in diagnosing and treating patients with PH was 8.5 +/- 3.7 years. Pulmonary arterial hypertension (PAH) was the most frequent group (69%) followed by group 4 PH (19%), group 3 PH (8%), and combined pre- and post-capillary PH (4%). PAH associated with congenital heart disease (APAH-CHD) was the most frequent subgroup (47%) of PAH. Most of the patients' functional class (FC) at the time of diagnosis was III. The right heart catheterization (RHC) rate was 11.9 +/- 11.6 per month. Most frequently used vasoreactivity agent was intravenous adenosine (60%). All patients under targeted treatments were periodically for FC, six-minute walking test, and echo measures at 3-month intervals. AdCCs repeated RHC in case of clinical worsening (CW). The annual rate of hospitalization was 14.9 +/- 19.5. In-hospital use of intravenous iloprost reported from 16 AdCCs in CWs. Bosentan and ambrisentan, as monotreatment or combination treatment (CT), were noted in 845 and 28 patients, respectively, and inhaled iloprost, subcutaneous treprostinil, and intravenous epoprostenol were noted in 283, 30, and four patients, respectively. Bosentan was the first agent used for CT in all AdCCs and iloprost was the second. Routine use of antiaggregant, anticoagulant, and pneumococcal and influenza prophylaxis were restricted in only two AdCCs. Conclusion: Our nationwide data illustrate the current status of PH regarding clinical characteristics and practice patterns.en_US
dc.identifier.doi10.14744/AnatolJCardiol.2017.7549
dc.identifier.endpage250en_US
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue4en_US
dc.identifier.pmid29076824en_US
dc.identifier.scopus2-s2.0-85032735270en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage242en_US
dc.identifier.trdizinid243725en_US
dc.identifier.urihttps://doi.org/10.14744/AnatolJCardiol.2017.7549
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/243725
dc.identifier.urihttps://hdl.handle.net/11616/92484
dc.identifier.volume18en_US
dc.identifier.wosWOS:000417874800004en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Soc Cardiologyen_US
dc.relation.ispartofAnatolian Journal of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectpulmonary hypertensionen_US
dc.subjectpreliminary survey data of Turkeyen_US
dc.titlePreliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu